• Explore /
  • Poster
  • / Elevated pretreatment serum IL-8 and PD-L1 and overall survival in a phase III randomized advanced pancreatic cancer clinical trial.

Elevated pretreatment serum IL-8 and PD-L1 and overall survival in a phase III randomized advanced pancreatic cancer clinical trial.

Abstract Poster

Authors

null

Ashok Maddukuri

Penn State Hershey College of Medicine, Hershey, PA

Ashok Maddukuri , Prashanth Reddy Moku , Hyma Vani Polimera , Vinod Nagabhairu , Suhail M. Ali , Kim Leitzel , Joseph J. Drabick , Scott Halstead , Todd Umstead , Daniel Mckeone , Aamnah Ali , Joyson Poulose , Neha Pancholy , Harry Menon , Howard Spiegel , Allan Lipton

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Citation

J Clin Oncol 37, 2019 (suppl; abstr 4131)

DOI

10.1200/JCO.2019.37.15_suppl.4131

Abstract #

4131

Poster Bd #

236

Abstract Disclosures

Similar Posters

First Author: Jaffer A. Ajani

First Author: Nourhan El Ahmar

First Author: Itamar Sela

First Author: Eric Nadler